TNON — Tenon Medical Income Statement
0.000.00%
Last trade - 00:00- $6.53m
- -$0.00m
- $3.28m
- 21
- 39
- 15
- 14
Annual income statement for Tenon Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.044 | 0.16 | 0.691 | 2.93 | 3.28 |
| Cost of Revenue | |||||
| Gross Profit | 0.026 | 0.105 | -0.641 | 1.24 | 1.71 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 0.58 | 6.62 | 19.4 | 18.7 | 17 |
| Operating Profit | -0.536 | -6.46 | -18.7 | -15.7 | -13.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.705 | -7.08 | -18.9 | -15.6 | -13.7 |
| Net Income After Taxes | -0.705 | -7.08 | -18.9 | -15.6 | -13.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.585 | -7.05 | -18.9 | -15.6 | -13.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.585 | -7.05 | -18.9 | -15.6 | -13.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.17 | -50.2 | -189 | -68.7 | -11.3 |
| Dividends per Share |